Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sagmel, Inc. was a privately held pharmaceutical company headquartered in Libertyville, Illinois, specializing in the development, manufacturing, and marketing of over-the-counter (OTC) medications and nutritional supplements. The company established a dominant market presence in the Commonwealth of Independent States (CIS), including Russia, Ukraine, Kazakhstan, and Belarus, where it became a leading provider of consumer health products. Its portfolio featured well-known brands such as Theraflex for joint health, Nazol for nasal congestion, and Relief for hemorrhoid treatment. In 2008, Sagmel was acquired by Bayer HealthCare for approximately €265 million, significantly expanding Bayer's footprint in the rapidly growing Eastern European and CIS markets. Following the acquisition, Sagmel's operations and brand assets were fully integrated into Bayer's Consumer Care division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sagmel.